483 Vertex Pharmaceuticals Sep 2017

483 Vertex Pharmaceuticals Sep 2017

$119 - Not in Stock

FDA investigators audited the Vertex Pharmaceuticals - Boston, MA, United States facility and issued inspectional observations (via FDA 483) on 07 Sep 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 07 Sep 2017
  • Location: Boston, United States
  • FEI: 1000513211
Order